Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Selgelid (2008)
A Full-Pull Program for the Provision of Pharmaceuticals: Practical IssuesPublic Health Ethics, 1
Michael Ravvin (2008)
Incentivizing Access and Innovation for Essential Medicines: A Survey of the Problem and Proposed SolutionsPublic Health Ethics, 1
Thomas Pogge (2008)
Medicines for the World: Boosting Innovation without obstructing Free Access
T. Faunce, Hitoshi Nasu (2008)
Three Proposals for Rewarding Novel Health Technologies Benefiting People Living in Poverty. A Comparative Analysis of Prize Funds, Health Impact Funds and a Cost-Effectiveness/Competitive Tender TreatyPublic health ethics, 1
Thomas Pogge (2005)
HUMAN RIGHTS AND GLOBAL HEALTH: A RESEARCH PROGRAMMetaphilosophy, 36
The Health Impact Fund has been proposed as an optional, comprehensive advance market commitment system offering financial payments or prizes to patentees of new drugs, which are sold globally at an administered low price. The Fund is designed to offer payments based on the therapeutic impact of the drugs or vaccines, so that innovators will have efficient incentives to develop drugs that maximize health gains. Consumers would have improved access to such drugs because of low prices.
Public Health Ethics – Oxford University Press
Published: Jul 8, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.